0001415889-24-010425.txt : 20240405 0001415889-24-010425.hdr.sgml : 20240405 20240405165511 ACCESSION NUMBER: 0001415889-24-010425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240403 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeSimone Jill CENTRAL INDEX KEY: 0001930479 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 24827200 MAIL ADDRESS: STREET 1: C/O PRAXIS PRECISION MEDICINES, INC. STREET 2: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 form4-04052024_040404.xml X0508 4 2024-04-03 1 0001797768 Kinnate Biopharma Inc. KNTE 0001930479 DeSimone Jill 800 WEST EL CAMINO REAL SUITE 180 MOUNTAIN VIEW CA 94040 true false false false 0 Stock Option (right to buy) 5.21 2024-04-03 4 D 0 50000 D 2033-03-01 Common Stock 50000 0 D This option was cancelled pursuant to that certain Agreement and Plan of Merger, dated February 16, 2024, by and between the Issuer, XOMA Corporation and XRA 1 Corp. (the "Merger Agreement") in exchange for one non-transferable contingent value right ("CVR") for each share underlying such out-of-the-money option. However, please note that such CVRs will provide payment only after the amounts payable under such CVRs exceed a threshold equal to the excess of the per share exercise price of such out-of-the-money option over the Cash Amount. /s/ James P. Reilly, Attorney-in-Fact 2024-04-05